Pearl River Capital, LLC Gilead Sciences, Inc. Transaction History

Pearl River Capital, LLC

$0
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $3.53 Million - $4.31 Million	49,375 New	49,375 $3.62 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $5.53 Million - $6.03 Million	74,778 New	74,778 $5.6 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $1.97 Million - $2.25 Million	25,490 New	25,490 $2.11 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.26 Million - $2.54 Million	-39,074 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $2.08 Million - $2.61 Million	35,990 Added 1166.99%	39,074 $2.32 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $200,089 - $227,105	3,084 New	3,084 $224,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $685,496 - $739,574	-10,127 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $404,494 - $441,967	6,373 Added 169.77%	10,127 $697,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $36,300 - $41,418	-605 Reduced 13.88%	3,754 $243,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $950,077 - $1.08 Million	-16,771 Reduced 79.37%	4,359 $254,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $1.31 Million - $1.65 Million	21,130 New	21,130 $1.34 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $734,974 - $853,440	-10,160 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $103,652 - $132,764	1,655 Added 19.46%	10,160 $760,000
Q4 2019 Feb 26, 2020	BUY	$61.62 - $67.78 $165,264 - $181,785	2,682 Added 46.06%	8,505 $553,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $358,813 - $394,682	5,823 New	5,823 $378,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $116,393 - $128,478	-1,862 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $115,201 - $129,185	1,862 New	1,862 $126,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $126,373 - $141,571	-2,021 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $122,351 - $159,659	2,021 New	2,021 $126,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Account